Beyond CRC, the dysregulation and oncogenic role of SNHG15 has been indicated in various types of cancer, including gastric [47] and hepatocellular carcinoma [48], osteosarcoma [44], as well as pancreatic [49] and breast cancers [46]. Here, SNHG15 is linked to osteosarcoma.